Roche Is Sudden Pioneer In Alzheimer's Research With New Trial In Early Patients
With Alzheimer's disease drug research most recently characterized by setbacks, not breakthroughs, the field is shifting toward a biomarker-based approach that will allow for the treatment of patients earlier in the course of the disease – before they show symptoms.